IS7590A - 1-[(Indól-3-ýl)karbónýl] píperasín afleiður - Google Patents

1-[(Indól-3-ýl)karbónýl] píperasín afleiður

Info

Publication number
IS7590A
IS7590A IS7590A IS7590A IS7590A IS 7590 A IS7590 A IS 7590A IS 7590 A IS7590 A IS 7590A IS 7590 A IS7590 A IS 7590A IS 7590 A IS7590 A IS 7590A
Authority
IS
Iceland
Prior art keywords
indol
carbonyl
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
IS7590A
Other languages
English (en)
Other versions
IS2443B (is
Inventor
Martin Cowley Phillip
Caulfield Wilson
Tierney Jason
Cairns James
Adam-Worrall Julia
York Mark
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of IS7590A publication Critical patent/IS7590A/is
Publication of IS2443B publication Critical patent/IS2443B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
IS7590A 2002-06-21 2004-12-09 1-[(Indól-3-ýl)karbónýl] píperasín afleiður IS2443B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077505 2002-06-21
PCT/EP2003/050226 WO2004000832A1 (en) 2002-06-21 2003-06-13 1-[(indol-3-yl)carbonyl] piperazine derivatives

Publications (2)

Publication Number Publication Date
IS7590A true IS7590A (is) 2004-12-09
IS2443B IS2443B (is) 2008-11-15

Family

ID=29797228

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7590A IS2443B (is) 2002-06-21 2004-12-09 1-[(Indól-3-ýl)karbónýl] píperasín afleiður

Country Status (33)

Country Link
US (1) US7304064B2 (is)
EP (1) EP1549637B1 (is)
JP (1) JP4408804B2 (is)
KR (1) KR20050009755A (is)
CN (1) CN1298716C (is)
AR (1) AR040274A1 (is)
AT (1) ATE361290T1 (is)
AU (1) AU2003250245B2 (is)
BR (1) BR0311960A (is)
CA (1) CA2490141C (is)
CO (1) CO5680419A2 (is)
CY (1) CY1107677T1 (is)
DE (1) DE60313640T2 (is)
DK (1) DK1549637T3 (is)
EC (1) ECSP045503A (is)
ES (1) ES2285183T3 (is)
HK (1) HK1076630A1 (is)
HR (1) HRP20041186A2 (is)
IL (1) IL165572A0 (is)
IS (1) IS2443B (is)
MX (1) MXPA04012856A (is)
NO (1) NO20045351L (is)
NZ (1) NZ537143A (is)
PE (1) PE20040578A1 (is)
PL (1) PL375152A1 (is)
PT (1) PT1549637E (is)
RS (1) RS111104A (is)
RU (1) RU2318821C2 (is)
SI (1) SI1549637T1 (is)
TW (1) TW200402417A (is)
UA (1) UA78317C2 (is)
WO (1) WO2004000832A1 (is)
ZA (1) ZA200410057B (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
JP4667867B2 (ja) 2002-08-02 2011-04-13 メルク・シャープ・エンド・ドーム・コーポレイション 置換フロ［２，３−ｂ］ピリジン誘導体
DE10253426B4 (de) * 2002-11-15 2005-09-22 Elbion Ag Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
CA2549147C (en) * 2003-12-17 2012-04-10 Akzo Nobel N.V. Tricyclic 1-((3-indol-3-yl)carbonyl) piperazine derivatives as cannabinoid cb1 receptor agonists
TWI330635B (en) 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
EP1904068A1 (en) * 2005-07-11 2008-04-02 N.V. Organon Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
RU2422442C2 (ru) * 2005-07-29 2011-06-27 Ф. Хоффманн-Ля Рош Аг Производные индол-3-ил-карбонил-пиперидина и пиперазина
TW200745096A (en) * 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
WO2007038045A1 (en) * 2005-09-23 2007-04-05 Janssen Pharmaceutica, N.V. Tetrahydro-indazolyl cannabinoid modulators
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
RU2387642C2 (ru) 2007-10-31 2010-04-27 Общество С Ограниченной Ответственностью "Бинатех" Производные 5-замещенных индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение
GB201106817D0 (en) * 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
CN109336883B (zh) 2013-12-20 2022-06-14 阿斯特克斯治疗有限公司 双环杂环化合物及其治疗用途
TW201938164A (zh) * 2018-01-08 2019-10-01 瑞士商赫孚孟拉羅股份公司 新穎雜環化合物
CN108752342A (zh) * 2018-08-17 2018-11-06 西安瑞联新材料股份有限公司 1-H-吡啶并[1,2-a]-6-氢吡嗪-1,4-二酮的制备方法
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
EP1243268A4 (en) 1999-12-14 2003-05-21 Nippon Shinyaku Co Ltd MEDICINAL COMPOSITION
CA2399791A1 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases

Also Published As

Publication number Publication date
CN1298716C (zh) 2007-02-07
HRP20041186A2 (en) 2005-06-30
TW200402417A (en) 2004-02-16
AU2003250245A1 (en) 2004-01-06
ZA200410057B (en) 2005-10-20
IL165572A0 (en) 2006-01-15
EP1549637B1 (en) 2007-05-02
JP2005533801A (ja) 2005-11-10
PE20040578A1 (es) 2004-09-15
JP4408804B2 (ja) 2010-02-03
BR0311960A (pt) 2005-03-22
NZ537143A (en) 2005-05-27
MXPA04012856A (es) 2005-03-31
CA2490141A1 (en) 2003-12-31
ES2285183T3 (es) 2007-11-16
PT1549637E (pt) 2007-05-31
SI1549637T1 (sl) 2007-10-31
CY1107677T1 (el) 2013-04-18
RS111104A (en) 2007-02-05
ATE361290T1 (de) 2007-05-15
KR20050009755A (ko) 2005-01-25
EP1549637A1 (en) 2005-07-06
HK1076630A1 (en) 2006-01-20
US7304064B2 (en) 2007-12-04
DK1549637T3 (da) 2007-07-16
US20050250760A1 (en) 2005-11-10
WO2004000832A1 (en) 2003-12-31
DE60313640T2 (de) 2007-12-27
UA78317C2 (en) 2007-03-15
PL375152A1 (en) 2005-11-28
RU2005101349A (ru) 2005-06-27
NO20045351L (no) 2005-01-20
ECSP045503A (es) 2005-03-10
DE60313640D1 (de) 2007-06-14
CN1668611A (zh) 2005-09-14
AR040274A1 (es) 2005-03-23
IS2443B (is) 2008-11-15
CO5680419A2 (es) 2006-09-29
CA2490141C (en) 2011-01-25
AU2003250245B2 (en) 2008-07-03
RU2318821C2 (ru) 2008-03-10

Similar Documents

Publication Publication Date Title
HK1076630A1 (en) 1-(Indol-3-yl) carbonyl piperazine derivatives
DK1490355T3 (da) Indolylmaleimidderivater
DK1515969T3 (da) Spiroindolinpiperidinderivater
DE60336314D1 (de) Substituierte indole
DK1472255T3 (da) Aza-arylpiperaziner
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
IS7667A (is) Nýjar bensimídazólafleiður
NO20052487D0 (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
PL375220A1 (en) Piperidine derivatives
DE60322857D1 (de) Neues alpha-amino-n-(diaminophosphinyl)lactamderivat
ATE386518T1 (de) Benzimidazolderivate
IS7382A (is) Píperidínafleiður
DK1828154T3 (da) Phenylpiperazinmethanonderivater
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
ATE457299T1 (de) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
IS8002A (is) Setið indólín og indól afleiður
ATE285408T1 (de) Paroxetin-n-formyl-derivate
IS7022A (is) Nýjar indólafleiður
ATE405560T1 (de) Indolderivaten
DE602004003965D1 (de) Halogenalkyl- und piperidinsubstituierte benzimidazolderivate
DK1503988T3 (da) Fredericamycin-derivater
IS7871A (is) Tetrahýdrókínólín afleiður
DK1305307T3 (da) Indolderivater
ITPG20020077A1 (it) I politici